Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 1CAPITAL AND CODEINE
02 8CLOBAZAM
03 1EMFLAZA
04 1FLOLIPID
05 1FURADANTIN
06 2GRISEOFULVIN
07 1KIONEX
08 1LIKMEZ
09 1NAPROSYN
10 1NAPROXEN
11 1NITROFURANTOIN
12 3NYSTATIN
13 3PHENYTOIN
14 2SODIUM POLYSTYRENE SULFONATE
01 19175
02 118965
03 140028
04 140342
05 140521
06 162512
07 162876
08 165200
09 165438
10 174190
11 186024
12 189049
13 189892
14 190590
15 1201355
16 1203621
17 1206679
18 1208685
19 1208819
20 1209715
21 1210039
22 1210546
23 1210569
24 1210746
25 1211259
26 1213110
27 1216755
01 25No
02 2Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : NITROFURANTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 201355
Country : US
Patented : No
Drug : PHENYTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 89892
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 210039
Country : US
Patented : No
Drug : NAPROSYN
Dosage Form : SUSPENSION; ORAL
Application Number : 18965
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 208819
Country : US
Patented : No
Drug : FURADANTIN
Dosage Form : SUSPENSION; ORAL
Application Number : 9175
Country : US
Patented : No
Drug : NYSTATIN
Dosage Form : SUSPENSION; ORAL
Application Number : 203621
Country : US
Patented : No
Drug : EMFLAZA
Dosage Form : SUSPENSION; ORAL
Application Number : 208685
Country : US
Patented : No
Drug : FLOLIPID
Dosage Form : SUSPENSION; ORAL
Application Number : 206679
Country : US
Patented : Yes
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 211259
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
